Volz et al. conducted a retrospective analysis to find out more about the use of a proprietary lavender oil preparation over a longer period of time (>3 or >6 months) and to evaluate the usage behavior of 12-17-year-olds. For this purpose, they analyzed large data sets from Switzerland and Germany. The results are very informative and confirm the positive results of this widespread treatment option in a real-world setting.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis
More DMARDs can reduce glucocorticoids in LORA
- Atopic dermatitis
Implement the “minimal disease activity” concept
- Sensation of pain
Special features for people with multiple disabilities
- Atopic dermatitis
Clinic, therapy and prevention in early childhood
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- COPD exacerbations
Fast therapy initiation is not much better than expected
- Pain and autism